DCC PLC/ IE0002424939 /
2024-09-19 11:01:10 AM | Chg. +35.00 | Volume | Bid11:01:24 AM | Ask11:01:24 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
5,272.50GBX | +0.67% | 2,950 Turnover(GBP): 155,576.4750 |
5,275.00Bid Size: 1 | 5,295.00Ask Size: 15 | 5.22 bill.GBP | - | - |
GlobeNewswire
07-10
Metrc Extends Track-and-Trace Partnership Through New Contract with State of California
GlobeNewswire
03-07
USO brings Dallas Cowboys Cheerleaders on tour to U.S. service members and their families in Korea
GlobeNewswire
02-20
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busines...
GlobeNewswire
2023-11-06
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-10-25
Digital Check Corp. Adds Error Detection and Image Cleanup to its SecureLink by Digital Check® Netwo...
GlobeNewswire
2023-10-19
Vislink Amplifies Its Presence in U.S. Broadcast and Video Markets Via Strategic Agreement with AV D...
GlobeNewswire
2023-09-13
The University of St. Augustine for Health Sciences Leads the Charge Toward Effective, Compassionate...
GlobeNewswire
2023-08-28
CPI Aero Receives Second Multi-Year Contract and Funded Order for F-16 Aircraft Structures
GlobeNewswire
2022-03-28
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in N...
GlobeNewswire
2022-03-08
New AMD Ryzen Threadripper PRO 5000 WX-Series Processors are the Ultimate Workstation Processors for...
GlobeNewswire
2022-03-01
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busines...
GlobeNewswire
2022-02-15
Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
GlobeNewswire
2021-11-08
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-08-09
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update